China’s President Pushes for Leveling the COVID-19 Vaccination Playing Field & Calls for Pharma to Transfer IP

With a myriad of vaccine passports set up or in the planning stages across various regions in Europe as well as nations such as Australia or America, some national leaders are calling for a sort of harmonization of vaccine acceptance. There is mutual recognition of the vaccines for targeting SARS-CoV-2 with the World Health Organization (WHO) emergency use authorization listing. China has taken the same position, as seen in a video speech that was given by the nation’s President, Xi Jinping, at the 16th Group of 20 Leaders’ Summit. China seeks an international COVID-19 vaccine initiative that would level the playing field for several vaccines in market circulation. During the session, Jinping implied that national governments should consider encouraging pharmaceutical companies to accept vaccine-based technology transfers to low-and middle-income countries (LMICs). The Chinese President attempted to position to the influential inter-governmental forum, which included representation from 19 countries and the European Union, evidence of China’s vaccine diplomacy, that is use of COVID-19 vaccines for nation branding as a method for projecting power. More than likely on the President’...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee